New Zealand Archives - LifeScienceHistory.com

Novavax Nuvaxovid COVID-19 vaccine granted expanded provisional approval in New Zealand for adolescents aged 12 through 17

Biotechnology | COVID-19 | Infectious Disease | Life Science News | Vaccine

Novavax Nuvaxovid COVID-19 vaccine granted expanded provisional approval in New Zealand for adolescents aged 12 through 17

On Aug. 18, 2022, Novavax announced that New Zealand’s Medsafe had granted expanded provisional approval for Nuvaxovid (NVX-CoV2373)…

New Zealand’s Medsafe granted provisional approval for Novavax’ COVID-19 vaccine

Biotechnology | COVID-19 | Infectious Disease | Life Science News | Vaccine

New Zealand’s Medsafe granted provisional approval for Novavax’ COVID-19 vaccine

On Feb. 3, 2022, Novavax announced that New Zealand’s Medsafe had been granted provisional approval of NVX-CoV2373, Novavax’…

Novavax filed COVID-19 vaccine for provisional approval in New Zealand

Biotechnology | Infectious Disease | Life Science News | Vaccine

Novavax filed COVID-19 vaccine for provisional approval in New Zealand

On Nov. 3, 2021, Novavax announced the company had filed for provisional approval of the vaccine to the…

Novavax announced agreement with government of New Zealand for 107 million doses of COVID-19 vaccine

Biotechnology | COVID-19 | Infectious Disease | Life Science News | Vaccine

Novavax announced agreement with government of New Zealand for 107 million doses of COVID-19 vaccine

On Dec. 16, 2020, Novavax announced an Advance Purchase Agreement with the government of New Zealand for the…